Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Selecta Biosciences to Present at Canaccord Genuity’s 39th Annual Growth Conference on August 7, 2019
-
Selecta Biosciences (SELB) PT Lowered to $13 at Canaccord Genuity
-
Selecta Biosciences (SELB) Prices 20M Share Common Offering at $1.50/Sh
-
Selecta Biosciences Announces Pricing of Public Offering of Common Stock
-
Selecta Biosciences (SELB) to Offer Common Stock
-
Selecta Biosciences Announces Proposed Public Offering of Common Stock
-
Selecta Biosciences (SELB) PT Lowered to $25 at Canaccord Genuity
-
Selecta Biosciences to Present at the Canaccord Growth Conference on August 9, 2018
-
Selecta Biosciences (SELB) PT Raised to Street High $40 at Canaccord Genuity
-
Selecta Biosciences (SELB) Defended at Canaccord, 'BUY on Weakness'
-
Selecta Biosciences (SELB) PT Raised to $30 at Canaccord Genuity
-
Selecta Biosciences to Participate in Two Investor Conferences in February
-
Selecta Biosciences to Present at Canaccord Genuity Growth Conference
-
Canaccord Genuity Starts Selecta Biosciences (SELB) at Buy
-
Selecta Biosciences Announces Closing of Initial Public Offering
-
Selecta Biosciences (SELB) IPO Opens, Trades Modestly Higher
-
Selecta Biosciences (SELB) Prices Common Stock IPO at $14/Share, at Low-End of Range
-
Selecta Biosciences Announces Pricing of Initial Public Offering
